Brief: NeuBase Therapeutics Says Qtrly Loss Per Share $0.40
14/08/2019 21:10
Aug 14 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
FISCAL
THIRD QUARTER OF 2019
* NEUBASE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.40
* NEUBASE THERAPEUTICS INC - AT JUNE 30, 2019, COMPANY HAD
CASH
AND CASH EQUIVALENTS OF APPROXIMATELY $1.4 MILLION
Source text for Eikon: ID:nGNX1C6vng
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet